Cytek Biosciences Inc (CTKB) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 10.57%53.23 | 48.14 | 44.14 | 62.14 | 52.29 |
| Cost Of Revenue | 11.23%22.02 | 19.80 | 22.88 | 29.26 | 24.74 |
| Gross Profit | 10.11%31.21 | 28.34 | 21.25 | 32.89 | 27.55 |
0.28%39.63 | 39.74 | 39.72 | 38.48 | 36.74 | |
| Research and Development | 3.96%9.36 | 9.74 | 9.60 | 8.96 | 8.96 |
| Operating Income/Loss | 26.11%-8.42 | -11.40 | -18.46 | -5.59 | -9.19 |
| Nonoperating Income/Loss | 723.46%1.52 | -0.24 | 1.09 | 1.56 | 1.42 |
| Income Tax Expense/Benefit, Deferred | - | - | -0.18 | 38.58 | -2.63 |
| Income Tax Expense/Benefit | 257.48%-0.81 | 0.52 | 1.49 | 40.05 | -2.29 |
49.85%-6.10 | -12.16 | -18.87 | -44.08 | -5.48 | |
| Attributable To Parent | 49.85%-6.10 | -12.16 | -18.87 | -44.08 | -5.48 |
| Available To Common Stockholders, Basic | 49.85%-6.10 | -12.16 | -18.87 | -44.08 | -5.48 |
| Basic Average Shares | 0.69%130.36 | 129.46 | 128.70 | 0.14 | 127.55 |
| Diluted Average Shares | 0.69%130.36 | 129.46 | 128.70 | 0.14 | 127.55 |